Skip to content

Neurodynamic Interventions for Multiple Sclerosis

Effects of Neurodynamic Interventions to Multimodal Physical Therapy in Patients With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03595631
Enrollment
32
Registered
2018-07-23
Start date
2018-07-26
Completion date
2018-10-04
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

neurodynamics, pain

Brief summary

A randomized, parallel-group, clinical trial will be conducted to compare the immediate effects of the inclusion of a neurodynamic intervention into a multimodal physiotherapy program on pressure pain sensitivity, pain and manual dexterity in patients with multiple sclerosis

Interventions

OTHERPhysical Therapy

Patients will receive 5 session of multimodal physiotherapy treatment of 30min duration including low-load strength exercises, soft tissue mobilization and muscle-tendon stretching exercises twice per week.

OTHERPhysical Therapy plus Neurodynamic

Patients will receive 5 session of multimodal physiotherapy treatment of 30min duration including low-load strength exercises, soft tissue mobilization and muscle-tendon stretching exercises twice per week. In addition, they will also receive bilateral nerve slider neurodynamic interventions targeting the median, ulnar and radial nerves.

Sponsors

Universidad Rey Juan Carlos
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* a diagnosis of multiple sclerosis according to the modified McDonald criteria; * symptoms of paresthesia and lack of sensitivity in the upper extremity; * Expanded Disability Status Scale (EDSS) between 0 and 6.5 points; * absence of cognitive deficit.

Exclusion criteria

* any exacerbation of multiple sclerosis during the previous 3 months; * previous hand surgery or steroid injections treatment in the upper extremity; * multiple diagnoses on the upper extremity (e.g., cervical radiculopathy); * cervical, shoulder, or upper extremity trauma; * other comorbid musculoskeletal medical conditions; * mini-mental state examination \<25

Design outcomes

Primary

MeasureTime frameDescription
Changes in pressure pain sensitivityBaseline and one week after the last treatment sessionPressure pain threshold over the median, ulnar and radial nerves, second metacarpal and tibialis anterior

Secondary

MeasureTime frameDescription
Changes in upper extremity pain intensity before and after the interventionBaseline and one week after the last treatment sessionA Numerical Pain Rate Scale (NPRS, 0-10) will be used to record the mean and the worst intensity of pain in te upper extremity
Changes in light touch detection thresholdBaseline and after treatmentBaseline and one week after the last treatment sessionLight touch detection threshold will be assessed with a standardized set of modified twenty von Frey hairs
Changes in manual dexterityBaseline and one week after the last treatment sessionBilateral manual dexterity was bilaterally assessed using the nine-hole peg test

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026